Drug intelligence / Profile preview

amitriptyline hydrochloride + choline

Development stage
Unknown
Lead developer
Merck
Modality
Small Molecules
Administration
Oral
01

Overview

**Amitriptyline hydrochloride + choline** is an oral combination product marketed as **Sentra PM** or **SentraVil PM**, described as a convenience-packed medical food and drug kit distributed by Targeted Medical Pharma through Physician Therapeutics. The pharmaceutical component is **amitriptyline hydrochloride**, a small-molecule tricyclic antidepressant that inhibits presynaptic reuptake of **serotonin** and **norepinephrine**, while the accompanying choline component is supplied as **choline bitartrate** within a proprietary nutritional formulation that may also include amino acids and related ingredients. The product appears to have been positioned primarily around depression-related use, although amitriptyline itself is also used more broadly for disorders such as major depressive disorder, neuropathic pain, and migraine prevention. Based on the provided context, this is best understood as a combination product that includes an established antidepressant together with a choline-containing medical food formulation rather than a novel molecular entity.

Brand names
Sentra PMSentraVil PM
Other names
amitriptyline hydrochloride + cholineamitriptyline hydrochloride + choline bitartrate
02

Targets

DAT (Dopamine plasma membrane transport protein)mAChR (Muscarinic acetylcholine receptors)HRH1 (Histamine H1 Receptor)SERT (Sodium-dependent serotonin transporter)NET (Norepinephrine Transporter)

Beyond the preview

Go deeper on amitriptyline hydrochloride + choline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on amitriptyline hydrochloride + choline.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call